Arcturus Therapeutics Holdings (ARCT) Return on Sales [ROS] (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) reported Return on Sales [ROS] of -863.30% for Q2 2026, down 822.25 percentage points from -41.04% a year earlier but up 540.44 percentage points from the prior quarter.
Arcturus Therapeutics Holdings (ARCT) Return on Sales [ROS] (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arcturus Therapeutics Holdings' Return on Sales [ROS] came in at -348.33%, down 288.91 percentage points year-over-year; for FY2025, it came in at -92.96%, down 30.15 percentage points from FY2024.
- Return on Sales [ROS] has declined for three consecutive years, though with a five-year change of +656.84 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -62.81% in FY2024 (-15.93 pp), -46.89% in FY2023 (-52.80 pp), 5.91% in FY2022 (+1647.24 pp) and -1641.33% in FY2021 (-891.52 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -2208.49% in Q3 2021 and a high of 75.77% in Q4 2022.
- Year over year, Return on Sales [ROS] has now declined in each of the last four quarters, with an average year-over-year change of -321.75 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q2 2022 (a gain of 2603.13 percentage points); the low point was Q1 2026 (a drop of 1346.47 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -1403.74% (Q1 2026), -435.06% (Q4 2025) and -96.27% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Arcturus Therapeutics Holdings | 370.35 Mn | -443.78 Mn | - | -863.30% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -863.30% |
| Mar 31, 2026 | -1,403.74% |
| Dec 31, 2025 | -435.06% |
| Sep 30, 2025 | -96.27% |
| Jun 30, 2025 | -41.04% |
| Mar 31, 2025 | -57.27% |
| Dec 31, 2024 | -146.68% |
| Sep 30, 2024 | -25.76% |
| Jun 30, 2024 | -42.37% |
| Mar 31, 2024 | -80.01% |
| Dec 31, 2023 | -59.22% |
| Sep 30, 2023 | -42.79% |
| Jun 30, 2023 | -526.42% |
| Mar 31, 2023 | 18.38% |
| Dec 31, 2022 | 75.77% |
| Sep 30, 2022 | -275.32% |
| Jun 30, 2022 | -81.53% |
| Mar 31, 2022 | -960.70% |
| Dec 31, 2021 | -649.72% |
| Sep 30, 2021 | -2,208.49% |
Arcturus Therapeutics Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();